Review: In type 2 diabetes, adding dipeptidyl peptidase-4 inhibitors to sulphonylureas increases hypoglycemia

被引：0
|
作者：
Tanner, Michael [1 ]
机构：
[1] NYU, Sch Med, New York, NY 10016 USA
来源：
ANNALS OF INTERNAL MEDICINE | 2016年 / 165卷 / 04期
关键词：
D O I：
10.7326/ACPJC-2016-165-4-020
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：JC20 / JC20
页数：1
相关论文
共 50 条
  • [31] Dipeptidyl peptidase-4 inhibitors in the management of type 2 diabetes: safety, tolerability, and efficacy
    Cox, Mary Elizabeth
    Rowell, Jennifer
    Corsino, Leonor
    Green, Jennifer B.
    DRUG HEALTHCARE AND PATIENT SAFETY, 2010, 2 : 7 - 19
  • [32] The Role of Dipeptidyl Peptidase-4 Inhibitors in Fat Metabolism in Patients with Type 2 Diabetes
    Ametov, Alexander S.
    DIABETES, 2017, 66 : A627 - A627
  • [33] Dipeptidyl peptidase-4 inhibitors alleviate cognitive dysfunction in type 2 diabetes mellitus
    Jie Meng
    Rui Yan
    Chen Zhang
    Xueyan Bai
    Xingsheng Yang
    Yu Yang
    Tao Feng
    Xin Liu
    Lipids in Health and Disease, 22
  • [34] Addition of dipeptidyl peptidase-4 inhibitors to sulphonylureas and risk of hypoglycaemia: systematic review and meta-analysis
    Salvo, Francesco
    Moore, Nicholas
    Arnaud, Mickael
    Robinson, Philip
    Raschi, Emanuel
    De Ponti, Fabrizio
    Begaud, Bernard
    Pariente, Antoine
    BMJ-BRITISH MEDICAL JOURNAL, 2016, 353
  • [35] Emerging dipeptidyl peptidase-4 inhibitors for the treatment of diabetes
    Ahren, Bo
    EXPERT OPINION ON EMERGING DRUGS, 2008, 13 (04) : 593 - 607
  • [36] Treatment persistence, hypoglycaemia and clinical outcomes in type 2 diabetes patients with dipeptidyl peptidase-4 inhibitors and sulphonylureas: a primary care database analysis
    Rathmann, W.
    Kostev, K.
    Gruenberger, J. B.
    Dworak, M.
    Bader, G.
    Giani, G.
    DIABETES OBESITY & METABOLISM, 2013, 15 (01): : 55 - 61
  • [37] Pharmacoeconomic evaluation of dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes mellitus: a systematic literature review
    Ruan, Zhen
    Zou, Huimin
    Lei, Qing
    Ung, Carolina Oi Lam
    Shi, Honghao
    Hu, Hao
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2022, 22 (04) : 555 - 574
  • [38] Predictors of the Efficacy of Dipeptidyl Peptidase-4 Inhibitors in Taiwanese Patients with Type 2 Diabetes Mellitus
    Lin, Yi-Hsin
    Huang, Hsuan
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2019, 12 : 2725 - 2733
  • [39] Type 2 Diabetes Treatment Recommendations Update: Appropriate Use of Dipeptidyl Peptidase-4 Inhibitors
    Cornell, Susan
    JOURNAL OF DIABETES & METABOLISM, 2014, 5 (08)
  • [40] Dipeptidyl peptidase-4 inhibitors in type 2 diabetic elderly patient
    Doucet, Jean
    Bauduceau, Bernard
    Blickle, Jean-Frederic
    GERIATRIE ET PSYCHOLOGIE NEUROPSYCHIATRIE DE VIEILLISSEMENT, 2011, 9 (02): : 157 - 162
12345